InsidersTradesSigma
Explore the complete record of transactions filed by Novak Rodger, Président. Insider active across 1 companies, notably CRISPR Therapeutics AG. Cumulatively, 6 reports have been logged. Total volume traded: €13.8m. The latest transaction was disclosed on 30 June 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Rodger Novak is the President of CRISPR Therapeutics AG. In this role, he oversees strategic operations and ensures growth and innovation. CRISPR Therapeutics AG is a biotechnology company specializing in genome editing. Rodger plays a key role in developing the company's vision and objectives.